Dusseldorf It is bitter news for investors who have opted for the electric car industry: Manufacturers of electrically powered vehicles have been losing value massively since the beginning of the year. The Tesla share, for example, was still at a record level last October with prices well over 1,000 dollars, but the price has fallen by 40 percent since January.
Elon Musk’s company is still in a relatively good position: competitor Lucid has lost more than 60 percent, the e-pickup manufacturer Rivian even a full 74 percent. The only ones who are currently making money from the crash in the electric car industry are so-called short sellers – i.e. investors who are betting on falling prices.
What the decline of the e-car manufacturers is related to, how short sellers benefit from the price drop and what risks are associated with this investment technique: Handelsblatt Today host Agatha Kremplewski talks to US correspondent Felix Holtermann about this. Holtermann also explains the importance of the stock market crash for the e-mobility industry and whether this will inhibit the development of e-cars into mass products.
Also in the new episode: Vaccines against monkeypox are currently in high demand. This gives the manufacturers sometimes heavy price gains: The biotech company Bavarian Nordic, for example, recently gained up to 80 percent. Although experts still estimate the extent of the infectious disease as low, some investors now seem to be counting on the vaccine manufacturers. Is it worth joining here? Market analyst Konstantin Oldenburger from CMC Markets explains what is behind the hype surrounding monkeypox vaccine manufacturers.
Top jobs of the day
Find the best jobs now and
be notified by email.
We have an exclusive subscription offer for you as a Handelsblatt Today listener. Interested? Then take a look.
If you have any comments, questions, criticism or praise for this episode, please email us at: [email protected]